My Density Matters is hosting the 5th Annual Find out My Breast Density Day. DYK almost half of all women have dense breast tissue which means they are at higher risk of developing breast cancer, and mammograms may not be as effective for them? We’re joining My Density Matters to spread awareness that today is Find Out My Breast Density Day – check your mammogram report to empower yourself with this information, talk to your doctor if you have questions, and remind all the women in your life to do the same. At Exai, we are motivated every day to advance our blood test to detect breast cancer early. #BreastDensity #EarlyDetection #Checkyourchart? #Accelerateaction
Exai Bio
生物技术研究
Palo Alto，California 5,472 位关注者
Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis.
关于我们
Exai Bio is a next-generation liquid biopsy company. Our mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. The company’s proprietary RNA and artificial intelligence-based liquid biopsy platform delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer. Exai Bio was founded with technology from the UCSF laboratory of Dr. Hani Goodarzi, and consists of veteran leaders in the RNA biology, liquid biopsy, and artificial intelligence/machine learning fields from both academia (UCSF, Stanford, MIT) and industry (Bluestar, CareDx, Evidation, Google, 23andMe, Deep Genomics). Exai Bio is supported by leading life sciences and tech investors including Section 32, Casdin Capital, and Two Sigma Ventures, who have been integral to advancing cancer diagnostics, and artificial intelligence and machine learning technologies. We know that people are our greatest asset and we are rapidly building a rock-star team of talent. Our people are driven by the mission, inspired by the vision of the future, and are committed to living our core values (integrity, openness, teamwork, exploration, and kindness) that connect us to our work and to one another. What We Value Our core values represent what we stand for as a team. This is what we believe in. Everyday, we strive to align our behaviors to these core values in everything we do. Integrity – Our thoughts and actions are true to science and to people. We do the right thing. Openness – We recognize and respect our differences – and embrace learning from them. Teamwork – We are team players who trust and respect each other. Exploration – We are explorers, putting curiosity into action. Kindness – We are kind whenever possible – and we believe it’s always possible.
- 网站
-
https://exai.bio
Exai Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Palo Alto，California
- 类型
- 私人持股
- 创立
- 2021
地点
-
主要
获取路线
3350 W Bayshore Rd
US，California，Palo Alto，94303
Exai Bio员工
动态
-
Together we unite to fight cancer and inspire hope.?#WorldCancerDay #UnitedByUnique #EarlyDetection #BreastCancer
-
-
Exai Bio转发了
Congratulations to our Board Director Karen Knudsen MBA PhD for receiving the 2025 Allen Lichter Visionary Leader Award from American Society of Clinical Oncology (ASCO). Your tremendous leadership and dedication continue to make a profound impact on cancer care. We are grateful for all you do to improve the lives of cancer patients.?#ASCO25 #Exai #Oncology #Leadership https://lnkd.in/gWnXB9gz
-
Congratulations to our Board Director Karen Knudsen MBA PhD for receiving the 2025 Allen Lichter Visionary Leader Award from American Society of Clinical Oncology (ASCO). Your tremendous leadership and dedication continue to make a profound impact on cancer care. We are grateful for all you do to improve the lives of cancer patients.?#ASCO25 #Exai #Oncology #Leadership https://lnkd.in/gWnXB9gz
-
#ICYMI, our own Mehran Karimzadeh wrote a blog post about our recent Nature Communications publication demonstrating superior cancer detection performance by Exai’s AI platform compared to traditional machine learning methods. #AI #RNA #EarlyDetection #LungCancer https://lnkd.in/ggpQyQe9 https://lnkd.in/gyTFebqb
-
Today, we honor the legacy of Dr. Martin Luther King Jr., whose words continue to inspire us: “The time is always right to do what is right.” At Exai Bio, we are committed to doing what is right—advancing cancer detection and ensuring a future where everyone has access to earlier detection and better health. #MLKDay, #Inspiration, #Leadership
-
The most recent American Cancer Society annual report included the alarming trend that breast cancer rates are continuing to rise and have been climbing since the mid-2000s, especially in younger women. This underscores the pressing need for continued research, awareness and early detection of this disease. Exai is motivated every day to do its part in bringing forth a blood test to detect breast cancer. #BreastCancer #EarlyDetection #LiquidBiopsy https://lnkd.in/g_hZEBkP
-
We are honored to welcome Karen Knudsen MBA PhD, MBA, PhD, to our board of directors.?As an internationally recognized oncology leader and immediate past CEO of the American Cancer Society and its advocacy affiliate ACS CAN, Karen is deeply committed to ending cancer as we know it. Her guidance will be invaluable as we advance our test to detect breast cancer for women with dense breast tissue. #breastcancer #earlydetection #densebreast #RNA #AI
-
??New Publication Alert in Nature Communications ?? Our latest publication features our novel generative AI platform, showcasing superior performance in detecting lung cancer compared to traditional machine learning methods. Generative AI combined with unique RNA biomarkers will play a central role in liquid biopsy and delivering on the promise of early cancer detection.#AI #HealthTech #EarlyDetection #LungCancer Read the full publication here: https://lnkd.in/gFbrywag https://lnkd.in/gyVNjqgb
-
Exai was proud to be part of the inaugural RISE UP For Breast Cancer Meeting hosted by UCSF. #breastcancer #womenshealth #UCSF
-